| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adjuvant treatment after radical surgery for cervical cancer with intermediate risk factors: is it time for an update?
|
Rodriguez, Juliana
|
|
|
32 |
10 |
p. 1219-1226
|
artikel
|
| 2 |
A population-based study of outcomes in adjuvant radiotherapy for stage II endometrial carcinoma
|
Moldovan, Nataliya
|
|
|
32 |
10 |
p. 1258-1265
|
artikel
|
| 3 |
CERVANTES: an international randomized trial of radical surgery followed by adjuvant (chemo) radiation versus no further treatment in patients with early-stage, intermediate-risk cervical cancer (CEEGOG-CX-05; ENGOT-CX16)
|
Cibula, David
|
|
|
32 |
10 |
p. 1327-1331
|
artikel
|
| 4 |
Clinician attitude towards sexual counseling in women with gynecologic malignancies: European Network of Young Gynaecological Oncologists (ENYGO) survey
|
Kacperczyk-Bartnik, Joanna
|
|
|
32 |
10 |
p. 1309-1315
|
artikel
|
| 5 |
Correspondence on “Oncologic outcomes of surgical para-aortic lymph node staging in patients with advanced cervical carcinoma undergoing chemoradiation” by Nasioudis et al
|
Gorostidi, Mikel
|
|
|
32 |
10 |
p. 1351
|
artikel
|
| 6 |
Correspondence on “Oncologic outcomes of surgical para-aortic lymph node staging in patients with advanced cervical carcinoma undergoing chemoradiation” by Nasioudis et al
|
Martinez, Alejandra
|
|
|
32 |
10 |
p. 1353-1354
|
artikel
|
| 7 |
Early-stage intermediate-risk—the group with the most heterogenous management among patients with cervical cancer
|
Cibula, David
|
|
|
32 |
10 |
p. 1227-1228
|
artikel
|
| 8 |
Gynecological radio-induced secondary malignancy after a gynecological primary tumor: a rare entity and a challenge for oncologists
|
Barcellini, Amelia
|
|
|
32 |
10 |
p. 1321-1326
|
artikel
|
| 9 |
Impact of treatment modality on pelvic floor dysfunction among uterine cancer survivors
|
Lakomy, David S
|
|
|
32 |
10 |
p. 1266-1275
|
artikel
|
| 10 |
Incidence of lymph node metastasis in early-stage low-grade serous ovarian cancer: a systematic review
|
Viveros-Carreño, David
|
|
|
32 |
10 |
p. 1283-1288
|
artikel
|
| 11 |
Leiomyosarcoma after laparoscopic myomectomy
|
Daggez, Mine
|
|
|
32 |
10 |
p. 1348-1349
|
artikel
|
| 12 |
Loop colostomy formation with a skin bridge technique in a gynecological oncology center
|
Farrell, Robert Adam
|
|
|
32 |
10 |
p. 1344-1345
|
artikel
|
| 13 |
Multiple attempts at fertility preservation in atypical endometrial hyperplasia and early endometrial cancer
|
Darin, Maria Cecilia
|
|
|
32 |
10 |
p. 1332-1335
|
artikel
|
| 14 |
Myths and fake messages about human papillomavirus (HPV) vaccination: answers from the ESGO Prevention Committee
|
Taumberger, Nadja
|
|
|
32 |
10 |
p. 1316-1320
|
artikel
|
| 15 |
Oncologic and pregnancy outcomes after fertility-sparing surgery for stage I, low-grade endometrioid ovarian cancer
|
Swift, Brenna E
|
|
|
32 |
10 |
p. 1276-1282
|
artikel
|
| 16 |
Patient-reported drivers of financial toxicity in gynecologic cancers: a focus group study
|
Nicholson, Kaitlin
|
|
|
32 |
10 |
p. 1303-1308
|
artikel
|
| 17 |
Patient-reported outcomes in the GARNET trial in patients with advanced or recurrent mismatch repair-deficient/microsatellite instability-high endometrial cancer treated with dostarlimab
|
Kristeleit, Rebecca
|
|
|
32 |
10 |
p. 1250-1257
|
artikel
|
| 18 |
Peri-operative ovarian cancer guidelines: introduction, skin antisepsis, patient positioning, including retractors use and nutritional management
|
Fotopoulou, Christina
|
|
|
32 |
10 |
p. 1338-1340
|
artikel
|
| 19 |
Peri-operative ovarian cancer guidelines: prehabilitation, enhanced recovery, post-operative ileus prevention, post-operative physiotherapy and mobilization
|
Sehouli, Jalid
|
|
|
32 |
10 |
p. 1341-1343
|
artikel
|
| 20 |
Quality is more important than quantity: pre-operative sarcopenia is associated with poor survival in advanced ovarian cancer
|
Polen-De, Clarissa
|
|
|
32 |
10 |
p. 1289-1296
|
artikel
|
| 21 |
Response to: Correspondence on “Oncologic outcomes of surgical para-aortic lymph node staging in patients with advanced cervical carcinoma undergoing chemoradiation” by Gorostidi
|
Pareja, Rene
|
|
|
32 |
10 |
p. 1352
|
artikel
|
| 22 |
Significance of p53 and presence of differentiated vulvar intra-epithelial neoplasia (dVIN) at resection margin in early stage human papillomavirus-independent vulvar squamous cell carcinoma
|
Thompson, Emily F
|
|
|
32 |
10 |
p. 1229-1235
|
artikel
|
| 23 |
10 steps to approach large ovarian masses through vNOTES
|
Badiglian-Filho, Levon
|
|
|
32 |
10 |
p. 1346-1347
|
artikel
|
| 24 |
SUCCOR quality: validation of ESGO quality indicators for surgical treatment of cervical cancer
|
Boria, Felix
|
|
|
32 |
10 |
p. 1236-1243
|
artikel
|
| 25 |
Surgical training in Colombia: a ‘home-made’ cadaveric abdominal wall retractor
|
Sanabria, Daniel
|
|
|
32 |
10 |
p. 1336-1337
|
artikel
|
| 26 |
Survey on implementation of molecular testing in ovarian cancer and PARP inhibitor: a national North-Eastern German Society of Gynecologic Oncology/Young Academy of Gynecologic Oncology/Arbeitsgemeinschaft Gynäkologische Onkologie intergroup analysis
|
Nguyen-Sträuli, Bich Doan
|
|
|
32 |
10 |
p. 1297-1302
|
artikel
|
| 27 |
UTERUS 11 is a negative trial
|
Pareja, Rene
|
|
|
32 |
10 |
p. 1350
|
artikel
|
| 28 |
Validation of a sustainable internationally monitored cervical cancer screening system using a visual smartphone inspection in Kinshasa, Democratic Republic of Congo
|
Tendobi, Celine
|
|
|
32 |
10 |
p. 1244-1249
|
artikel
|
Tijdschrift beschrijving